A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo

Clinical trial NCT00918957 · COMPLETED

Trial details

NCT number: NCT00918957
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2009-06-01
Primary completion: 2011-05-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.